Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

The safety of a calorie deficit for weight loss depends on things like your starting weight, overall health and unique ...

Food, exercise, sleep, hydration. So much goes into weight loss. But how does weight loss work, exactly? In the simplest ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...